Posters
| P01 | Factor V deficiency In Algeria: Single center experience Moueden Mohamed Amine, Algeria |
|
| P02 | Drug-immune thrombocytopenia with thrombosis versus heparin-induced thrombocytopenia: A critical clinical controversy Hassan A. Al-Jafar, Kuwait |
|
| P03 | Chemotherapy induced tumour microparticle release in vitro Saeed Alqarni, UK |
|
| P04 | Hemostatic changes in blood in post major orthopaedic surgery patients under the condition of low molecular weight heparin and tranexamic acid treatment Irina Antropova, Russia |
|
| P05 | Severe deficiency of Factor V: A case report in the perioperative setting Ricard Mellado Artigas, Spain |
|
| P06 | Comparison of the treatment outcome of anticoagulation versus catheter-directed thrombolysis with stenting for patients with May-Thurner Syndrome Annamarie Pineda Borja, Singapore |
|
| P07 | An improvement of score models in the prediction of Deep Vein Thrombosis of both upper and lower limbs in hospitalized patients Antonella Maria Cardella, Italy |
|
| P08 | Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in sickle cell disease thrombotic microangiopathies Mingyi Chen, USA |
|
| P09 | Predicting bleeding risk in patients on vitamin K antagonists treatment Benlaldj Driss, Algeria |
|
| P10 | Compound Factor V and Factor VIII deficiency in Algeria Benlaldj Driss, Algeria |
|
| P11 | Ultrasonic real-time monitoring of drug-induced fibrinolysis in blood flow Shakhla Dzhumaeva, Russia |
|
| P12 | Outcome of surgical intervention in patients with May-Thurner Syndrome Chaozer Er, Singapore |
|
| P13 | Venous thromboembolism occurence in 2 cases of stroke in the young: Is chronic antiplatelet prophylaxis enough? Aissa Althea Flavier Hundal, Singapore |
|
| P14 | ADAMTS-13 stable in citrated whole blood for 48 hours Rebekah Fretwell, UK |
|
| P15 | The retinal hemorrhage during fraxiparine treatment Aleksandra Gergont, Poland |
|
| P16 | Role of anticoagulation vs. anti-platelet in young patients with first episode of arterial thrombosis Peiyan Ho, Singapore |
|
| P17 |
A case of multiple arterial and venous thromboembolisms with chronic stage of SLE and occult lymphoma |
|
| P18 | Prothrombotic genetic variants and risk of premature idiopathic ischemic stroke Rosa María Jiménez-Alvarado, Mexico |
|
| P19 | Does prescribing mechanical Venous Thrombo Embolism (VTE) prophylaxis improve compliance with their use in surgical inpatients? Parminder Kaur, UK |
|
| P20 | FV-Leiden and FII-G20210 for spontaneous abortions. Physicians keep ask for the tests! Theoni Kanellopoulou, Greece |
|
| P21 | Screening women with miscarriages for MTHFR polymorphisms. Is there any clinical utility? Theoni Kanellopoulou, Greece |
|
| P22 | Combined heterozygosity for Factor V Leiden and Prothrombin G20210 mutation and recurrent venous thromboembolism. Should we suspect an additional risk factor? Theoni Kanellopoulou, Greece |
|
| P23 | Clinical and radiological features in patients with neuromyelitis optica and anti-phosphopolipid antibody syndrome: A case-series study Kwang-Ho Lee, Korea |
|
| P24 | Hemostatic potential in postoperatve patients with colon cancer Iuliia Malysheva, Russia |
|
| P25 | How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy? László Muszbek, Hungary |
|
| P26 | Contribution of contact activation pathway to the hypercoagulable state in sickle cell disease Rafal Pawlinski, USA |
|
| P27 | Rivaroxaban to treat patients with gynecological cancer and venous thromboembolism at the Hospital of Cancer II /Inca-Brazil Marcos Jose Pereira Renni, Brazil |
|
| P28 | Venous thromboembolism risk and use of prophylaxis in chronically ill patients at home care Ana Rocha, Brazil |
|
| P29 | A forgotten enemy. Hemorheologic abnormalities as a cause thrombosis in some myeloproliferative neoplasms Eugene Roitman, Russia |
|
| P30 | Genetic risk factors for atherothrombotic disease in young individuals: Comparation between myocardial infarction and ischemic stroke Irma Salas, Mexico |
|
| P31 | Angiotensin-converting enzyme insertion/deletion and angiotensinogen M235T polymorphisms and the risk of idiopathic ischemic stroke in young individuals Irma Isordia Salas, Mexico |
|
| P32 | Congenital thrombotic thrombocytopenic purpura: New mutation. Case report Hector Sarmiento, Spain |
|
| P33 | Elevated Factor VIII levels in liver disease: Acute phase reactant or a marker of liver coagulopathy? Priyanka Saxena, India |
|
| P34 | Hemostatic alterations in patients with alcoholic cirrhosis-scenario from a developing country Priyanka Saxena, India |
|
| P35 | Drug resistant pulmonary embolism as a manifestation of choriocarcinoma Anna Śniady, Poland |
|
| P36 |
High prevalence of Glanzmann thrombasthenia at Almadinah, Saudi Arabia: A single center experience |
|
| P37 | The impact of the using of oral coagulants on the incidence of colorectal cancer diagnoses: Single center experience Jacek Zielinski, Poland |
|
| P38 | Shear stress and Willebrand multimer length as control parameters of platelets activation Ksenia Zlobina, Russia |
|
| P39 | The impact of the metabolic syndrome on erythrocyte aggregation in Ischemic stroke patients Marine Tanashyan, Russia |
|
| P40 | Rheological and biochemical parameters of endothelial function at different degrees of carotid atherosclerosis in patients with Ischemic stroke Marine Tanashyan, Russia |